Letters to the Editor

Hematologic complications in patients exposed to poly-ADP ribose polymerase inhibitors

Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL
Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL
Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL
Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL
Northwest Cancer Centers, Dyer, IN
Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL
Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL
Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL
Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL
Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL
Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL
Department of Pathology, University of Chicago, Chicago, IL
Department of Pathology, University of Chicago, Chicago, IL
Department of Pathology, University of Chicago, Chicago, IL
Department of Pathology, University of Chicago, Chicago, IL
Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA; Section of Hematology/Oncology, Department of Pediatrics, University of Chicago, Chicago, IL
Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA; Section of Genetic Medicine, Department of Medicine, University of Chicago, Chicago, IL
Haematologica Early view Jan 29, 2026 https://doi.org/10.3324/haematol.2025.288518